Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
TGA:5
Drug Approvals
ENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial (423019)
- Product Name
- ENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial
- Approval Date
- Apr 16, 2025
TGA
VYXEOS daunorubicin (as hydrochloride) 44 mg and cytarabine 100 mg powder for injection vial (363250)
- Product Name
- VYXEOS daunorubicin (as hydrochloride) 44 mg and cytarabine 100 mg powder for injection vial
- Approval Date
- Jun 3, 2022
TGA
EPIDYOLEX cannabidiol 100 mg/mL oral liquid solution bottle (328860)
- Product Name
- EPIDYOLEX cannabidiol 100 mg/mL oral liquid solution bottle
- Approval Date
- Sep 21, 2020
TGA
DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial (319221)
- Product Name
- DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial
- Approval Date
- Jul 23, 2020
TGA
Sativex Oromucosal Spray, nabiximols 80 mg/mL pump actuated metered dose aerosol (181978)
- Product Name
- Sativex Oromucosal Spray, nabiximols 80 mg/mL pump actuated metered dose aerosol
- Approval Date
- Nov 26, 2012
TGA
Clinical Trials
No trials found
News
No news found